Advocacy intelligence hub — real-time data for patient organizations
Xuanwu Hospital, Beijing — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Patricia E Hewitt, FRCP FRCPath
NHS Blood and Transplant
Tuan Le, MD
Oklahoma Blood Institute
David Hoover, MD
ICON plc
Michael Stevenson, MD
Oklahoma Blood Institute
John Collinge, MD, FRCP
MRC Prion Unit
Theresa M Marteau, PhD FMedSci
King's College London